If you only have a morning in Lisbon, the Fundação Calouste Gulbenkian is your best bet. It was started by the eponymous ...

The Finnish composer Kaija Saariaho, who died in 2023, wrote music of profoundly shadowed seriousness, and her ironically ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this week, including a cancer drug from ImmunityBio (IBRX) and Moderna's (MRNA) ...

Moderna's narrative is shifting as analysts modestly trim their fair value from $37.32 to $35.78 per share and nudge the discount rate from 7.13% to 7.13%, reflecting a slightly higher required return ...

Pluribus season 1 soundtrack features Dave Porter’s original score and classic licensed songs, adding eerie, retro vibes that ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine skepticism rises, according to Moderna (MRNA) co-founder and chairman Noubar ...

If you’re the type of person who has dubstep, Southern hip-hop, and Koji Kondo’s iconic “Ground Theme” from Super Mario Bros.

Anaconda 2025 released on December 25, 2025. Here’s a guide to the songs featured in the film that matched its horrifying yet ...

Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that it had secured a five-year loan of $1.5 billion from Ares Management Corp ...

Approximately 2 hours and 35 minutes, including one 20 minute intermission. The year is 1943 and right now we’re losing the war. Luckily, we’re about to gamble all our futures on a stolen corpse.

The Moderna booster decision essentially matches FDA's ruling that high-risk groups are eligible for the Pfizer vaccine, which is made with the same technology. FDA recommended that everyone who'd ...